These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2568151

  • 1. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: a comparison of young and older mice.
    Nishi K, Kondo T, Narabayashi H.
    Brain Res; 1989 Jun 05; 489(1):157-62. PubMed ID: 2568151
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S, Fujitake J, Kuno S, Sano Y.
    Neurosci Lett; 1988 Jul 19; 90(1-2):57-62. PubMed ID: 2901058
    [Abstract] [Full Text] [Related]

  • 3. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal biopterin in BALB/c mice.
    Lee EH.
    Neurosci Lett; 1988 Jun 07; 88(3):297-302. PubMed ID: 3260360
    [Abstract] [Full Text] [Related]

  • 4. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.
    Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu I, Nagatsu T.
    Neurosci Lett; 1987 Sep 23; 80(2):213-8. PubMed ID: 2891089
    [Abstract] [Full Text] [Related]

  • 5. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
    Mayer RA, Walters AS, Heikkila RE.
    Eur J Pharmacol; 1986 Jan 29; 120(3):375-7. PubMed ID: 2868908
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF).
    Date I, Notter MF, Felten SY, Felten DL.
    Brain Res; 1990 Aug 27; 526(1):156-60. PubMed ID: 1706636
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice.
    Date I, Felten SY, Felten DL.
    Neurosci Lett; 1989 Dec 04; 106(3):282-6. PubMed ID: 2601883
    [Abstract] [Full Text] [Related]

  • 13. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat.
    Matsuda LA, Schmidt CJ, Hanson GR, Gibb JW.
    Neuropharmacology; 1986 Mar 04; 25(3):249-55. PubMed ID: 2871513
    [Abstract] [Full Text] [Related]

  • 14. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK, Keyghobadi M, Moore C, Meshul CK.
    Neuroscience; 2005 Mar 04; 136(1):333-41. PubMed ID: 16198485
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
    Petzinger GM, Fisher B, Hogg E, Abernathy A, Arevalo P, Nixon K, Jakowec MW.
    J Neurosci Res; 2006 Feb 01; 83(2):332-47. PubMed ID: 16385585
    [Abstract] [Full Text] [Related]

  • 17. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism.
    Schneider JS, Yuwiler A.
    Exp Neurol; 1989 Aug 01; 105(2):177-83. PubMed ID: 2568945
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M.
    J Neurosci Res; 2007 Jun 01; 85(8):1752-61. PubMed ID: 17469135
    [Abstract] [Full Text] [Related]

  • 20. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.
    Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu T.
    J Neurochem; 1988 Apr 01; 50(4):1053-6. PubMed ID: 2894407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.